Predictive Vulnerability Intelligence.

Product

  • Product
  • Pricing
  • Documentation

Company

  • About
  • Partnerships
  • Blog
  • Support

Legal

  • Terms
  • Privacy
  • Data Licensing

© 2026 FAUCET Technologies LLC. All rights reserved.

CVE-2022-26238

20
FAUCET Score

CVE-2022-26238 describes a privilege escalation vulnerability in Beckman Coulter Remisol Advance v2.0.12.1 and earlier, affecting Windows environments. Non-privileged users can exploit default service permissions to overwrite executables and libraries, potentially leading to unauthorized access to sensitive data. With a CVSS score of 5.5 (Medium), this vulnerability has a low attack complexity and requires local access, but can result in high confidentiality impact. Currently, there is no known active exploitation, publicly available exploit code (Metasploit, Nuclei, ExploitDB), or significant community discussion or media coverage.

Impacted Technologies

VendorProductVersion(s)CPE
<= 2.0.12.1CPE matchmatch criteria
cpe:2.3:a:beckmancoulter:remisol_advance:*:*:*:*:*:*:*:*

CVSS Data

CVSS version used by this source: 3.1

5.5MEDIUM

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Attack Vector
LOCAL
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
NONE
Availability Impact
NONE
Exploitability Score
1.8
Impact Score
3.6
CvssVersion
3.1

Exploit Intelligence

EPSS Score
0.20%
Probability of exploitation in next 30 days
EPSS Percentile
10.2%
Percentile rank of EPSS score among Peer Group
As of 2026-07-27
Model: v2026.06.15
This CVE's current EPSS score of 0.0020 is in the 49th percentile among its peer group of 15,940 CVEs.

Social Chatter

The average CVE in this peer group has 0.0 Twitter, 0.0 Reddit, 0.0 Bluesky, 0.0 Mastodon, and 0.1 GitHub mentions.

Media Mentions

No media coverage found for this CVE.

The average CVE in this peer group has 0.1 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.

Remediation

Remediation records are not available for this CVE.

References

pastebin.com / 23N5wcC7
Third Party Advisory
beckmancoulter.com / products/clinical-information-management-tools/remisol-advance
Product